ATE338545T1 - Polymaleinimid-verbindungen und ihre medizinische verwendung - Google Patents
Polymaleinimid-verbindungen und ihre medizinische verwendungInfo
- Publication number
- ATE338545T1 ATE338545T1 AT02801965T AT02801965T ATE338545T1 AT E338545 T1 ATE338545 T1 AT E338545T1 AT 02801965 T AT02801965 T AT 02801965T AT 02801965 T AT02801965 T AT 02801965T AT E338545 T1 ATE338545 T1 AT E338545T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- polymaleinimide
- medical uses
- relates
- maleimide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 3
- 150000003923 2,5-pyrrolediones Chemical class 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- -1 maleimide compound Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000028172 protozoa infectious disease Diseases 0.000 abstract 1
- 210000004994 reproductive system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
- C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0125658.5A GB0125658D0 (en) | 2001-10-25 | 2001-10-25 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338545T1 true ATE338545T1 (de) | 2006-09-15 |
Family
ID=9924532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02801965T ATE338545T1 (de) | 2001-10-25 | 2002-10-24 | Polymaleinimid-verbindungen und ihre medizinische verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050148653A1 (de) |
| EP (1) | EP1438042B1 (de) |
| AT (1) | ATE338545T1 (de) |
| AU (1) | AU2002334233A1 (de) |
| DE (1) | DE60214578T2 (de) |
| ES (1) | ES2269814T3 (de) |
| GB (1) | GB0125658D0 (de) |
| WO (1) | WO2003035058A2 (de) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3129225A (en) * | 1961-06-07 | 1964-04-14 | Us Vitamin Pharm Corp | Novel 4-oxy-3-maleimidyl betaines |
| DE1545848A1 (de) * | 1965-08-23 | 1969-10-16 | Bayer Ag | Verfahren zur Herstellung von Maleinimiden bzw. Isomaleinimiden |
| US4810638A (en) * | 1986-07-24 | 1989-03-07 | Miles Inc. | Enzyme-labeled antibody reagent with polyalkyleneglycol linking group |
| WO1989004318A1 (fr) * | 1987-11-11 | 1989-05-18 | Toray Industries, Inc. | Complexe de platine et agent therapeutique contre les tumeurs malignes |
| US4876358A (en) * | 1987-11-25 | 1989-10-24 | Texaco Inc. | Oxyethylene bismaleimide derivatives |
| US5380746A (en) * | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| CA2047078A1 (en) * | 1990-07-19 | 1992-01-20 | Steven S. Bondy | Cyclic hiv principal neutralizing determinant peptides |
| JPH04120004A (ja) * | 1990-09-07 | 1992-04-21 | Ichikawa Gosei Kagaku Kk | 防菌防かび剤 |
| JPH05178825A (ja) * | 1991-12-26 | 1993-07-20 | Yamanouchi Pharmaceut Co Ltd | 新規なペプチド誘導体 |
| US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
| US5539132A (en) * | 1994-01-24 | 1996-07-23 | Johns Hopkins University | Cerulenin compounds for fatty acid synthesis inhibition |
| US6001555A (en) * | 1994-09-23 | 1999-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| US5658940A (en) * | 1995-10-06 | 1997-08-19 | Celgene Corporation | Succinimide and maleimide cytokine inhibitors |
| JP3329161B2 (ja) * | 1995-10-31 | 2002-09-30 | 松下電器産業株式会社 | 非水電解液二次電池 |
| JP2863638B2 (ja) * | 1996-01-26 | 1999-03-03 | ベーリンガー マンハイム コーポレイション | ビスーマレイミド架橋剤 |
-
2001
- 2001-10-25 GB GBGB0125658.5A patent/GB0125658D0/en not_active Ceased
-
2002
- 2002-10-24 AT AT02801965T patent/ATE338545T1/de not_active IP Right Cessation
- 2002-10-24 WO PCT/GB2002/004798 patent/WO2003035058A2/en not_active Ceased
- 2002-10-24 EP EP02801965A patent/EP1438042B1/de not_active Expired - Lifetime
- 2002-10-24 AU AU2002334233A patent/AU2002334233A1/en not_active Abandoned
- 2002-10-24 DE DE60214578T patent/DE60214578T2/de not_active Expired - Lifetime
- 2002-10-24 US US10/493,428 patent/US20050148653A1/en not_active Abandoned
- 2002-10-24 ES ES02801965T patent/ES2269814T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB0125658D0 (en) | 2001-12-19 |
| WO2003035058A2 (en) | 2003-05-01 |
| AU2002334233A1 (en) | 2003-05-06 |
| EP1438042A2 (de) | 2004-07-21 |
| DE60214578D1 (de) | 2006-10-19 |
| US20050148653A1 (en) | 2005-07-07 |
| WO2003035058A3 (en) | 2003-12-31 |
| DE60214578T2 (de) | 2007-09-13 |
| ES2269814T3 (es) | 2007-04-01 |
| EP1438042B1 (de) | 2006-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04012965A (es) | Inhibidores virales. | |
| MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| WO1998056761A3 (en) | Benzimidazole derivatives | |
| AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| WO2002055496A8 (en) | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | |
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| JO2282B1 (en) | Oxazole derivatives | |
| EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
| ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| EA200500376A1 (ru) | Триазольные производные в качестве ингибиторов трансформирующего фактора роста (tgf) | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
| MY146279A (en) | Compounds affecting glucokinase | |
| DE60315492D1 (de) | Medizinisch verwendbare arylethanolamin verbindungen | |
| EA200500377A1 (ru) | Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf) | |
| NO20092033L (no) | Nye forbindelser | |
| MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
| GB0112348D0 (en) | Compounds | |
| MXPA05006889A (es) | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. | |
| SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
| CA2430967A1 (en) | Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| UA83832C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение | |
| IL166057A0 (en) | Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |